May 30, 2017 05:15 ET | Source: Research and Markets <\/p>\n
Dublin, May 30, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the \"Biosimilars Market Access in Psoriasis\" report to their offering. <\/p>\n
Tumor necrosis factor (TNF)-alpha inhibitors Enbrel, Humira, and Remicade have long held dominant positions in the psoriasis market; however, these market leaders face patent expirations and consequent biosimilar launches. <\/p>\n
Payers are eager to leverage these changes in the competitive landscape and enact pro-biosimilar access measures, resulting in downward pricing pressures and\/or continuing market erosion for first-generation TNF-alpha inhibitors. This rate of erosion may initially be gradual, as neither physicians nor payers are likely to advocate patient switching. <\/p>\n
Key Topics Covered: <\/p>\n
1. Executive Summary<\/p>\n
2. Five Major EU Markets<\/p>\n
3. Methodology <\/p>\n
For more information about this report visit http:\/\/www.researchandmarkets.com\/research\/7tcv43\/biosimilars<\/a> <\/p>\n Related Articles <\/p>\n Research and Markets Logo <\/p>\n LOGO URL | Copy the link below <\/p>\n Formats available: <\/p>\n <\/p>\n Go here to read the rest: May 30, 2017 05:15 ET | Source: Research and Markets Dublin, May 30, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the \"Biosimilars Market Access in Psoriasis\" report to their offering. Tumor necrosis factor (TNF)-alpha inhibitors Enbrel, Humira, and Remicade have long held dominant positions in the psoriasis market; however, these market leaders face patent expirations and consequent biosimilar launches. Payers are eager to leverage these changes in the competitive landscape and enact pro-biosimilar access measures, resulting in downward pricing pressures and\/or continuing market erosion for first-generation TNF-alpha inhibitors Continue reading
\nBiosimilars Market Access in Psoriasis 2017: TNF-alpha inhibitors Enbrel, Humira, and Remicade have Long Held ... - GlobeNewswire (press release)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"